Top news of the week: 16.11.2021.
Healthcare
Biogen Announces Alfred W. Sandrock, Jr. to Retire as Head of Research & Development
CAMBRIDGE, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today that Alfred “Al” W. Sandrock, Jr., M.D., Ph.D., Head of...
In shock move, Biogen chief medical officer Al Sandrock will stand down
Shock as Biogen chief medical officer Al Sandrock announces his retirement, as biotech is struggling to deal with the contentious FDA approval of Alzheimer's drug Aduhelm
Investigating Antidepressants’ Surprising Effect on COVID Deaths
Researchers are still puzzling over what this drug does at the molecular level to help COVID patients
Advanced Medical Genetics Co. Notches 66% YoY Increase in Q3 Revenue Research Report
Invitae Corp. reported Q3/21 financial results that highlighted an 89% YoY increase in billable volume to 296,000 tests. Ladenburg Thalmann & Co. Inc. stated in a research note that it has ...
What Went Wrong at uBiome, Part 2
uBiome raised millions of dollars in venture funding with the promise that insurance companies would pay for its customers' microbiome tests. But that pursuit ultimately led to an FBI raid ...
Coave Therapeutics appoints Chief Medical Officer and Chief Operating Officer
Coave Therapeutics (Coave), a clinical-stage biotechnology company backed by international life science and strategic investors Seroba Life Sciences, Théa Open Innovation, eureKARE, Fund+, ...
10 Public Safety Update_SPIKEVAX_11 November 2021
1 The European Centre for Disease Prevention and Control (ECDC) collects these exposure data from EU Member States as well as from the additional countries of the European …